$0.9764
0.02782.93%
Last update: Nov 10, 6:12 PM
Firefly Neuroscience Inc
AIFFNASDAQ
Firefly Neuroscience fell 41.8% from $1.63 to $0.95, behind the S&P 500's +10.0%. Its worst day was Mar 20 (−29.8%), and its low came Feb 23 at $0.64.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.20 was reported on $388,000.00 revenue.
+5.5% · S&P 500 +0.1%
Firefly Neuroscience closed at its lowest level of the year, 60.9% below where the year started.
Story events cover the past 12 months · Times ET
−8.2% · S&P 500 −1.0%
- Company reports 20-fold expansion of commercial footprint, 33-fold increase in EEG/ERP brain scan volumes - - Harnessing increased data and cutting-edge supercomputing potentially unlocks new AI-driven biomarker
+126.3%, the year's best day, on 319M shares, the year's heaviest volume · S&P 500 +0.7%
Entry into a Material Definitive Agreement.
+58.0% · S&P 500 −0.6%
EPS of $-0.15 was reported on $412,000.00 revenue.
−0.9% · S&P 500 +2.9%
EPS of $-0.13 was reported on $485,000.00 revenue.
0.0% · S&P 500 +0.6%
EPS of $-0.10 was reported on $514,000.00 revenue.
−4.2% · S&P 500 −0.3%
– This integration of Firefly’s FDA 510(k)-cleared, AI-powered EEG/ERP technology follows Radial’s August 2026 acquisition of the management services organization supporting Mindful Health Solutions, forming the
+37.6% · S&P 500 +0.9%
Collaboration to use Firefly’s growing nationwide network of Evoke™ clinician customers.
+68.9% · S&P 500 +0.5%
Where it ended: a close of $0.95 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All AIFF analyst actionsNothing in the past 12 months.
All AIFF dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AIFF and SPY from Benzinga historical bars. Not investment advice.
